You are here

Velcade

ASCO: GSK builds case for return of multiple myeloma drug Blenrep

BioPharma Dive

Sun, 06/2/24 - 02:45 pm

mutliple myeloma

Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma

Clinical Trials Arena

Mon, 08/29/22 - 10:32 am

clinical trials

Multiple Myeloma

Fighting for market share, J&J expects last year's copycat pain to 'bleed into 2020'

Fierce Pharma

Wed, 01/22/20 - 06:32 pm

Janssen obtains FDA approval for Darzalex (multiple myeloma)

GoinPharma

Sun, 05/13/18 - 03:52 pm

Multiple Myeloma

With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022

Fierce Pharma

Tue, 07/18/17 - 11:28 am

Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo

Fierce Pharma

Fri, 07/14/17 - 07:54 am

Multiple Myeloma

With patent loss looming, Takeda knocks proposed Velcade copycats in FDA petition

Fierce Pharma

Mon, 06/26/17 - 05:03 pm

Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study

Yahoo/Reuters

Tue, 02/28/17 - 11:12 am

Multiple Myeloma

Top 10 U.S. patent losses of 2017

Fierce Pharma

Thu, 02/23/17 - 09:29 am

Sandostatin LAR

Bristol-Myers Squibb

Gilead Sciences

Amgen's multiple myeloma drug falls short in late stage study

Yahoo/Reuters

Tue, 09/27/16 - 10:18 am

Multiple Myeloma

clinical trials

J&J myeloma drug, in combo regimen, delays worsening of the disease

Yahoo/Reuters

Sun, 06/5/16 - 12:01 pm

Multiple Myeloma

Takeda's 'breakthrough' Velcade heir wins early FDA approval in myeloma

Fierce Biotech

Fri, 11/20/15 - 06:20 pm

Multiple Myeloma

U.S. court shaves 5 years off Velcade patent protection, generics could hit in 2017

Fierce Pharma

Mon, 08/24/15 - 11:36 am

Teva Pharmaceutical

Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial

Fierce Pharma

Tue, 03/3/15 - 08:05 am

ONYX Pharmaceuticals

Multiple Myeloma

Amgen's Kyprolis Outperforms Rival Drug In Study

Forbes

Mon, 03/2/15 - 08:05 am

Multiple Myeloma

Millennium drug Velcade approved for wider use in the US

Boston Globe, MA

Fri, 10/10/14 - 09:53 am

Millennium Pharmaceuticals

non-Hodgkin's lymphoma

Drugs That Will Help Johnson & Johnson Grow By 5% In 2014

Forbes

Wed, 04/30/14 - 10:28 am

J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment

Fierce Pharma

Tue, 11/12/13 - 04:37 pm

Multiple Myeloma

Is Johnson & Johnson Heading Off The Patent Cliff?

Seeking Alpha

Mon, 05/13/13 - 09:12 am

Celgene's Star Drug Revlimid And Its Competitors

Seeking Alpha

Sat, 03/30/13 - 10:57 am

Multiple Myeloma

Bristol-Myers Squibb

Pages